AI Tool Predicts Lung Cancer Chemo Response

Researchers have developed an AI pathology tool named PhenopyCell. It predicts how patients with extensive-stage small cell lung cancer respond to chemotherapy ^[1]. This tool analyzes existing biopsy slides without needing more samples ^[1]. PhenopyCell examines spatial arrangements of immune cells in tumors ^[1]. These patterns indicate if platinum-based treatments will be effective for the patient ^[1]. By forecasting outcomes, clinicians can avoid giving ineffective treatments to those who will not benefit ^[1]. This technology helps refine therapy choices for a difficult-to-treat cancer ^[1]. It uses deep learning to identify subtle cellular structures that humans might miss ^[1]. The goal is to provide personalized care for lung cancer patients earlier in their journey ^[1].